|
|
Ziagen (Abacavir)
| Brand Name: |
Ziagen |
| Generic Name: |
Abacavir, ABC |
| Adult Single Dose: |
One 300-mg tablet (twice a day) or two 300-mg
tablets (once a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
The Basics
- An Overview of Ziagen (Abacavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Ziagen (Abacavir Sulfate, ABC) (January/February 2008)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Ziagen (Abacavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Abacavir (Ziagen) (August 26, 2007)
From AIDS Treatment Data Network
- Abacavir (Ziagen) (August 17, 2007)
To read PDF, click here
From AIDS InfoNet
- Patient Information About Ziagen (Abacavir) (PDF) (October 2006)
From GlaxoSmithKline
- Ziagen (Abacavir) (May 2005)
To read PDF, click here
From The Center for AIDS
- Drug Interactions: Abacavir (August 2004)
From Project Inform
- HEPPigram: Management of the Abacavir Hypersensitivity Syndrome (AHS) (January 2002)
To read PDF, click here
In HEPP News, from Brown Medical School
News
- Guidelines Panel Responds to Abacavir Data (April 10, 2008)
From Project Inform
- Early Communication About an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine) (March 27, 2008)
From U.S. Food and Drug Administration
- Ziagen Pills Found in Fake Combivir Packaging (March 29, 2007)
To read PDF, click here
From GlaxoSmithKline
- Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
- Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Warnings About Hypersensitivity to Ziagen (Abacavir) (September 7, 2000)
In STEP Ezine, from Seattle Treatment Education Project
- Ziagen (Abacavir): New Warning on Restarting (August 4, 2000)
In AIDS Treatment News, from AIDS Treatment News
- Important Drug Warning: Severe Hypersensitivity Reactions Following Reintroduction With Ziagen (Abacavir Sulfate) Products (July 2000)
From U.S. Food and Drug Administration
- Hypersensitivity Reaction and Abacavir (Ziagen) (April 2000)
In What's New, from Project Inform
- Abacavir Warning: Certain Respiratory Symptoms Can Indicate Hypersensitivity Reaction (February 18, 2000)
From AIDS Treatment News
- Treatment Briefs: Changes in Warning on Abacavir Hypersensitivity (Winter 1999/2000)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Ziagen (Abacavir) Approved: Caution Essential (January 8, 1999)
From AIDS Treatment News
- FDA Approves Abacavir for HIV-1 Infection (December 18, 1998)
From U.S. Food and Drug Administration
- New Drug Pricing: Progress on World AIDS Day? (December 4, 1998)
Abacavir price announced.
From AIDS Treatment News
- Abacavir (Ziagen) Approval Recommended (November 6, 1998)
From AIDS Treatment News
- Abacavir's Trials and Tribulations (November 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Abacavir Struggles to Carve Out Niche (October 1998)
In TAGline, from Treatment Action Group
- Abacavir More Widely Available March 23 (March 20, 1998)
In AIDS Treatment News, from AIDS Treatment News
- Abacavir at Last (March 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
|
|
